Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924
- PMID: 12923612
- DOI: 10.1007/s00210-003-0788-2
Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924
Abstract
This study employed [(35)S]guanosine 5'- O-(3-thiotriphosphate) ([(35)S]GTPgammaS) binding to compare the actions of antipsychotic agents known to stimulate cloned, human 5-HT(1A) receptors with those of reference agonists at postsynaptic 5-HT(1A) receptors. In rat hippocampal membranes, the following order of efficacy was observed (maximum efficacy, E(max), values relative to 5-HT=100): (+)8-OH-DPAT (85), flesinoxan (62), eltoprazine (60), S14506 (59), S16924 (48), buspirone (41), S15535 (22), clozapine (22), ziprasidone (21), pindolol (7), p-MPPI (0), WAY100,635 (0), spiperone (0). Despite differences in species and tissue source, the efficacy and potency (pEC(50)) of agonists (with the exception of clozapine) correlated well with those determined previously at human 5-HT(1A) receptors expressed in Chinese hamster ovary (CHO) cells. In contrast, clozapine was more potent at hippocampal membranes. The selective antagonists p-MPPI and WAY100,635 abolished stimulation of binding by (+)8-OH-DPAT, clozapine and S16924 (p-MPPI), indicating that these actions were mediated specifically by 5-HT(1A) receptors. Clozapine and S16924 also attenuated 5-HT- and (+)8-OH-DPAT-stimulated [(35)S]GTPgammaS binding, consistent with partial agonist properties. In [(35)S]GTPgammaS autoradiographic studies, 5-HT-induced stimulation, mediated through 5-HT(1A) receptors, was more potent in the septum (pEC(50) approximately 6.5) than in the dentate gyrus of the hippocampus (pEC(50) approximately 5) suggesting potential differences in coupling efficiency or G protein expression. Though clozapine (30 and 100 microM) did not enhance [(35)S]GTPgammaS labelling in any structure, S16924 (10 micro M) modestly increased [(35)S]GTPgammaS labelling in the dentate gyrus. On the other hand, both these antipsychotic agents attenuated 5-HT (10 microM)-stimulated [(35)S]GTPgammaS binding in the dentate gyrus and septum. In conclusion, clozapine, S16924 and ziprasidone act as partial agonists for G protein activation at postsynaptic 5-HT(1A) receptors in the hippocampus. These data support a role of postsynaptic 5-HT(1A) receptors in the functional profiles of certain antipsychotic agents.
Similar articles
-
Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.Psychopharmacology (Berl). 2002 Jul;162(2):168-77. doi: 10.1007/s00213-002-1043-0. Epub 2002 Apr 30. Psychopharmacology (Berl). 2002. PMID: 12110994
-
Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation.Eur J Pharmacol. 2001 Oct 5;428(2):177-84. doi: 10.1016/s0014-2999(01)01344-9. Eur J Pharmacol. 2001. PMID: 11675034
-
The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [35S]GTPgammaS and [3H]S15535 autoradiography study.Eur J Pharmacol. 1999 Nov 19;384(2-3):111-21. doi: 10.1016/s0014-2999(99)00491-4. Eur J Pharmacol. 1999. PMID: 10611431
-
Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research.CNS Drugs. 2013 Sep;27(9):703-16. doi: 10.1007/s40263-013-0071-0. CNS Drugs. 2013. PMID: 23757185 Review.
-
Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson's disease.CNS Neurosci Ther. 2011 Feb;17(1):58-65. doi: 10.1111/j.1755-5949.2010.00211.x. Epub 2010 Nov 21. CNS Neurosci Ther. 2011. PMID: 21091640 Free PMC article. Review.
Cited by
-
Pinpointing brainstem mechanisms responsible for autonomic dysfunction in Rett syndrome: therapeutic perspectives for 5-HT1A agonists.Front Physiol. 2014 May 30;5:205. doi: 10.3389/fphys.2014.00205. eCollection 2014. Front Physiol. 2014. PMID: 24910619 Free PMC article.
-
Y-QA31, a novel dopamine D3 receptor antagonist, exhibits antipsychotic-like properties in preclinical animal models of schizophrenia.Acta Pharmacol Sin. 2016 Mar;37(3):322-33. doi: 10.1038/aps.2015.105. Epub 2016 Jan 18. Acta Pharmacol Sin. 2016. PMID: 26775662 Free PMC article.
-
Agonistic properties of a series of psychotropic drugs at 5-HT1A receptors in rat and human brain membranes determined by [35S]GTPγS binding assay.Pharmacol Rep. 2023 Apr;75(2):266-275. doi: 10.1007/s43440-023-00448-6. Epub 2023 Jan 13. Pharmacol Rep. 2023. PMID: 36637685
-
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.Pharmacol Rev. 2021 Jan;73(1):310-520. doi: 10.1124/pr.118.015552. Pharmacol Rev. 2021. PMID: 33370241 Free PMC article. Review.
-
Use of the GTPγS ([35S]GTPγS and Eu-GTPγS) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors.Br J Pharmacol. 2010 Nov;161(6):1238-49. doi: 10.1111/j.1476-5381.2010.00963.x. Br J Pharmacol. 2010. PMID: 20662841 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources